KB408

· Krystal Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KB408, covering 2025-07-22 to 2025-07-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency [Phase 1]